Siddique A, Williams K, Swami N
ACS Biomater Sci Eng. 2024; 11(1):672-681.
PMID: 39679605
PMC: 11733923.
DOI: 10.1021/acsbiomaterials.4c01298.
Dave K, Jain M, Sharma M, Delta A, Kole C, Kaushik P
Sci Rep. 2024; 14(1):22044.
PMID: 39333655
PMC: 11437285.
DOI: 10.1038/s41598-024-69635-6.
Cooke J, Youker K, Lai L
Methodist Debakey Cardiovasc J. 2024; 20(4):31-41.
PMID: 39184159
PMC: 11342844.
DOI: 10.14797/mdcvj.1400.
Bliley J, Stang M, Behre A, Feinberg A
Stem Cells Transl Med. 2024; 13(5):425-435.
PMID: 38502194
PMC: 11092277.
DOI: 10.1093/stcltm/szae014.
Khan A, Kumari P, Kumari N, Shaikh U, Ekhator C, Halappa Nagaraj R
Cureus. 2023; 15(8):e43431.
PMID: 37581196
PMC: 10423641.
DOI: 10.7759/cureus.43431.
Nanoengineering of gold nanoribbon-embedded isogenic stem cell-derived cardiac organoids.
Patino-Guerrero A, Esmaeili H, Migrino R, Nikkhah M
RSC Adv. 2023; 13(25):16985-17000.
PMID: 37288383
PMC: 10243308.
DOI: 10.1039/d3ra01811c.
Engineered Tissue for Cardiac Regeneration: Current Status and Future Perspectives.
Li J, Liu L, Zhang J, Qu X, Kawamura T, Miyagawa S
Bioengineering (Basel). 2022; 9(11).
PMID: 36354516
PMC: 9688015.
DOI: 10.3390/bioengineering9110605.
Engineering Spatiotemporal Control in Vascularized Tissues.
Khanna A, Oropeza B, Huang N
Bioengineering (Basel). 2022; 9(10).
PMID: 36290523
PMC: 9598830.
DOI: 10.3390/bioengineering9100555.
Engineering Cardiovascular Tissue Chips for Disease Modeling and Drug Screening Applications.
Chan A, Huang N
Front Bioeng Biotechnol. 2021; 9:673212.
PMID: 33959600
PMC: 8093512.
DOI: 10.3389/fbioe.2021.673212.
Patient-Specific 3D Bioprinted Models of Developing Human Heart.
Cetnar A, Tomov M, Ning L, Jing B, Theus A, Kumar A
Adv Healthc Mater. 2020; 10(15):e2001169.
PMID: 33274834
PMC: 8175477.
DOI: 10.1002/adhm.202001169.
Glial cells influence cardiac permittivity as evidenced through in vitro and in silico models.
Soucy J, Askaryan J, Diaz D, Koppes A, Annabi N, Koppes R
Biofabrication. 2019; 12(1):015014.
PMID: 31593932
PMC: 11062241.
DOI: 10.1088/1758-5090/ab4c0a.
Considerations for an , Cell-Based Testing Platform for Detection of Drug-Induced Inotropic Effects in Early Drug Development. Part 2: Designing and Fabricating Microsystems for Assaying Cardiac Contractility With Physiological Relevance Using Human....
Ribeiro A, Guth B, Engwall M, Eldridge S, Foley C, Guo L
Front Pharmacol. 2019; 10:934.
PMID: 31555128
PMC: 6727630.
DOI: 10.3389/fphar.2019.00934.
Graphene-based 3D scaffolds in tissue engineering: fabrication, applications, and future scope in liver tissue engineering.
Bai R, Muthoosamy K, Manickam S, Hilal-Alnaqbi A
Int J Nanomedicine. 2019; 14:5753-5783.
PMID: 31413573
PMC: 6662516.
DOI: 10.2147/IJN.S192779.
A Light Wand to Untangle the Myocardial Cell Network.
Zaglia T, Bona A, Mongillo M
Methods Protoc. 2019; 2(2).
PMID: 31164614
PMC: 6632158.
DOI: 10.3390/mps2020034.
Multicellular Interactions in 3D Engineered Myocardial Tissue.
Zamani M, Karaca E, Huang N
Front Cardiovasc Med. 2018; 5:147.
PMID: 30406114
PMC: 6205951.
DOI: 10.3389/fcvm.2018.00147.
International Multisite Study of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Proarrhythmic Potential Assessment.
Blinova K, Dang Q, Millard D, Smith G, Pierson J, Guo L
Cell Rep. 2018; 24(13):3582-3592.
PMID: 30257217
PMC: 6226030.
DOI: 10.1016/j.celrep.2018.08.079.
Concise Review: Tissue Engineering of Urinary Bladder; We Still Have a Long Way to Go?.
Adamowicz J, Pokrywczynska M, Van Breda S, Kloskowski T, Drewa T
Stem Cells Transl Med. 2017; 6(11):2033-2043.
PMID: 29024555
PMC: 6430044.
DOI: 10.1002/sctm.17-0101.
Anisotropic microfibrous scaffolds enhance the organization and function of cardiomyocytes derived from induced pluripotent stem cells.
Wanjare M, Hou L, Nakayama K, Kim J, Mezak N, Abilez O
Biomater Sci. 2017; 5(8):1567-1578.
PMID: 28715029
PMC: 5567776.
DOI: 10.1039/c7bm00323d.